Primary Job Title Partner Oslo Primary Organization 
Teknoinvest
Gender Male
Investor Type
Dr. Engelsen has been a member of Capnia's Board since 2003.
Since November 1996, Dr. Engelsen has been a partner of Teknoinvest AS, a venture capital firm based in Norway.
From 1989 until October 1996, Dr. Engelsen held various management positions within Hafslund Nycomed AS, a pharmaceutical company based in Europe, and affiliated
companies.
He was responsible for therapeutic research and development, most recently serving as Senior Vice President, Research and Development of Nycomed Pharma AS from January 1994 until October 1996.
He is currently on the Board of Directors of Insmed, Inc (NASDAQ:INSM). In addition, from January to November 2000.
Dr. Engelsen was acting Chief Executive Officer of Centaur Pharmaceuticals, Inc., a biopharmaceutical company.
Dr. Engelsen also served as Chairman of the Board of Directors of Centaur.
Dr. Engelsen received his MSc in Nuclear Chemistry.
His MD from the University of Oslo.
He is a Certified European Financial Analyst.
